PF-Atlas › Clinical Trials › NCT07712952

Validation of AI-Based Detection of Idiopathic Pulmonary Fibrosis in Serial Chest Radiographs: A Retrospective Longitudinal Study

VUNO Med-Chest X-ray · Not specified

Registry ID
NCT07712952
Phase
Not specified
Status
Completed
Drug / intervention
VUNO Med-Chest X-ray
Sponsor
Chung-Ang University Hospital
Enrollment
175
Locations
1

About this trial

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrotic lung disease of unknown cause with a median survival of only 3-5 years after diagnosis. Early detection and timely initiation of antifibrotic therapy may improve outcomes, but diagnosis is frequently delayed. Chest radiography (CXR) is widely accessible and cost-effective but has limited sensitivity for early interstitial opacity (IO), so radiologists may miss or delay documentation of relevant findings. This retrospective, single-center, observational cohort study evaluates whether an artificial-intelligence algorithm (VUNO Med-Chest X-ray) can detect interstitial opacity earlier than radiologists in the historical chest radiograph series of patients who were diagnosed with IPF. The cohort was identified via a April 2

View NCT07712952 on ClinicalTrials.gov →

Medical disclaimer. This page summarizes public trial data for NCT07712952 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.